Table 5.
Reference No. | Current Study | Current Study | 17 | 18 | 19 | 20 |
---|---|---|---|---|---|---|
Subjects (IS/C) | 307/324+583/270 | 710/3751 | 358/817 | 3104/4870 (2693/4320)* | 1606/2207 (845/1144)* | 774/1074 (661/1013)* |
Studies | Original+replication | Original | Original | 15 (11)* | 8 (3)* | 7 (6)* |
Population | European | European | European | Mix | Mix | Mix |
Analysis for each ethnic group | European | European | European | Yes | Yes | Yes |
SNPs (gene) | 342 (52 genes) | 212 (62 genes) | 60 (35 genes) | 1 (PAI-1) | 1 (TNFA) | 1 (ITGA2) |
Heterogeneity in ORs | Yes | Yes | Yes | |||
Use of covariates | Age, sex, AF, D, HT, MI, SM | Age, sex, D, HD, HT, SM | Age and sex | Age, sex, Ch, D, HT, SM | No | Age, sex, BMI, Ch, D, HT, SM |
Use of multiple testing correction | No | FDR | Yes | |||
Other features | Age range =45–57 | Association in child/Asian |
White samples.
C indicates control subjects; IS, ischemic stroke; AF, atrial fibrillation; BMI, body mass index; Ch, cholesterol; HD, heart disease; HT, hypertension; MI, myocardial infarction; SM, smoking; D, diabetes; FDR, false discovery rate.